The Safety Research of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

May 31, 2015

Conditions
RabiesHealthy
Interventions
BIOLOGICAL

2.5IU/ml in rabies vaccine (MRC-5 Cell) humans aged 10-20 years old

Freeze-dried Rabies Vaccine(MRC-5 Cell) of 2.5IU/ml,5 doses,4 weeks interval

BIOLOGICAL

2.5IU/ml rabies vaccine (MRC-5 Cell) in humans aged 21-60 years old

Freeze-dried Rabies Vaccine(MRC-5 Cell) of 2.5IU/ml,5 doses,4 weeks interval

BIOLOGICAL

2.5IU/ml rabies vaccine (MRC-5 Cell) in humans(from 10-20 years old)

Freeze-dried Rabies Vaccine(vero Cell) of 2.5IU/ml,5 doses,4 weeks interval

BIOLOGICAL

2.5IU/ml rabies vaccine (MRC-5 Cell) in humans(from 21-60 years old)

Freeze-dried Rabies Vaccine(vero Cell) of 2.5IU/ml,5 doses,4 weeks interval

Sponsors
All Listed Sponsors
collaborator

Beijing Minhai Biotechnology Co., Ltd

INDUSTRY

lead

Beijing Center for Disease Control and Prevention

OTHER_GOV